112 related articles for article (PubMed ID: 18974932)
1. A role for the p53 pathway in the pathology of meningiomas with NF2 loss.
Chang Z; Guo CL; Ahronowitz I; Stemmer-Rachamimov AO; MacCollin M; Nunes FP
J Neurooncol; 2009 Feb; 91(3):265-70. PubMed ID: 18974932
[TBL] [Abstract][Full Text] [Related]
2. PD-L1 regulates tumor proliferation and T-cell function in NF2-associated meningiomas.
Wang Y; Zhang C; Yan M; Ma X; Song L; Wang B; Li P; Liu P
CNS Neurosci Ther; 2024 Jun; 30(6):e14784. PubMed ID: 38828669
[TBL] [Abstract][Full Text] [Related]
3. Cases of Mixed Schwannoma-Meningioma With and Without Neurofibromatosis 2 with Emphasis on Tumorigenesis.
Rajeswarie RT; Mallik D; Rudrappa S; Gopal S
Int J Surg Pathol; 2024 May; 32(3):511-514. PubMed ID: 37487199
[TBL] [Abstract][Full Text] [Related]
4. An unusual finding of an anaplastic meningioma in NF2-related schwannomatosis.
Adelhoefer SJ; Feghali J; Rajan S; Eberhart CG; Staedtke V; Cohen AR
Childs Nerv Syst; 2024 Jul; 40(7):2209-2214. PubMed ID: 38451298
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity at 1p, 7q, 17p, and 22q in meningiomas.
Chang IB; Cho BM; Moon SM; Park SH; Oh SM; Cho SJ
J Korean Neurosurg Soc; 2010 Jul; 48(1):14-9. PubMed ID: 20717507
[TBL] [Abstract][Full Text] [Related]
6. Renal Cell Carcinoma Unclassified with Medullary Phenotype in a Patient with Neurofibromatosis Type 2.
Sarkar S; Throckmorton W; Bingham R; Msaouel P; Genovese G; Slopis J; Rao P; Sadighi Z; Herzog CE
Curr Oncol; 2023 Mar; 30(3):3355-3365. PubMed ID: 36975468
[TBL] [Abstract][Full Text] [Related]
7. A Rapid Robust Method for Subgrouping Non-NF2 Meningiomas According to Genotype and Detection of Lower Levels of M2 Macrophages in
Adams CL; Ercolano E; Ferluga S; Sofela A; Dave F; Negroni C; Kurian KM; Hilton DA; Hanemann CO
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32070062
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of MicroRNA Expression Depending on the Presence or Absence of Meningioma in Patients with Neurofibromatosis Type 2: A Secondary Analysis.
Imura T; Mitsuhara T; Horie N
Neurol Med Chir (Tokyo); 2024 Mar; 64(3):116-122. PubMed ID: 38267057
[TBL] [Abstract][Full Text] [Related]
9. Association of frequent NF2 mutations with spinal location predominance and worse outcomes in psammomatous meningiomas.
Ren L; Xie Q; Deng J; Chen J; Yu J; Wang D; Wakimoto H; Gong Y; Hua L
J Neurosurg; 2024 Mar; ():1-9. PubMed ID: 38552238
[TBL] [Abstract][Full Text] [Related]
10. Aggressive high-grade NF2 mutant meningiomas downregulate oncogenic YAP signaling via the upregulation of VGLL4 and FAT3/4.
Parrish AG; Arora S; Thirimanne HN; Rudoy D; Schmid S; Sievers P; Sahm F; Holland EC; Szulzewsky F
bioRxiv; 2024 May; ():. PubMed ID: 38854109
[TBL] [Abstract][Full Text] [Related]
11. Early phase clinical studies of AR-42, a histone deacetylase inhibitor, for neurofibromatosis type 2-associated vestibular schwannomas and meningiomas.
Welling DB; Collier KA; Burns SS; Oblinger JL; Shu E; Miles-Markley BA; Hofmeister CC; Makary MS; Slone HW; Blakeley JO; Mansouri SA; Neff BA; Jackler RK; Mortazavi A; Chang LS
Laryngoscope Investig Otolaryngol; 2021 Oct; 6(5):1008-1019. PubMed ID: 34667843
[TBL] [Abstract][Full Text] [Related]
12. Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas.
Youngblood MW; Duran D; Montejo JD; Li C; Omay SB; Özduman K; Sheth AH; Zhao AY; Tyrtova E; Miyagishima DF; Fomchenko EI; Hong CS; Clark VE; Riche M; Peyre M; Boetto J; Sohrabi S; Koljaka S; Baranoski JF; Knight J; Zhu H; Pamir MN; Avşar T; Kilic T; Schramm J; Timmer M; Goldbrunner R; Gong Y; Bayri Y; Amankulor N; Hamilton RL; Bilguvar K; Tikhonova I; Tomak PR; Huttner A; Simon M; Krischek B; Kalamarides M; Erson-Omay EZ; Moliterno J; Günel M
J Neurosurg; 2019 Oct; 133(5):1345-1354. PubMed ID: 31653806
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and survival of patients with spinal meningiomas: a large retrospective cohort study: Erratum.
Int J Surg; 2024 Apr; 110(4):2504. PubMed ID: 38668675
[No Abstract] [Full Text] [Related]
14. A comprehensive histomolecular characterization of meningioangiomatosis: Further evidence for a precursor neoplastic lesion.
Tauziède-Espariat A; Masliah-Planchon J; Sievers P; Sahm F; Dangouloff-Ros V; Boddaert N; Hasty L; Aboubakr O; Métais A; Chrétien F; Roux A; Pallud J; Blauwblomme T; Beccaria K; Bourdeaut F; Puget S; Varlet P
Brain Pathol; 2024 Apr; ():e13259. PubMed ID: 38565263
[TBL] [Abstract][Full Text] [Related]
15. P53 Suppressor Gene Tissue Microarray-based Protein Expression Analysis in Meningiomas.
Roukas D; Kouzoupis A; Spyropoulou D; Papanastasiou G; Tsiambas E; Tsouvelas G; Falidas E; Ragos V; Peschos D; Manaios L; Katsinis S; Manoli A; Papouliakos S; Lazaris AC; Kavantzas N
In Vivo; 2022; 36(5):2205-2210. PubMed ID: 36099147
[TBL] [Abstract][Full Text] [Related]
16. Nucleotide variations of
Bukovac A; Kafka A; Hrašćan R; Vladušić T; Pećina-Šlaus N
Mol Clin Oncol; 2019 Dec; 11(6):563-572. PubMed ID: 31692929
[TBL] [Abstract][Full Text] [Related]
17. Age-dependent copy number variations of TP53 tumour suppressor gene associated with altered phosphorylation status of p53 protein in sporadic schwannomas.
Chen H; Huang H; Zhao J; Wang Z; Chang M; Xue L; Zhu W; Chai Y; Li G; Wang Z; Wu H
J Neurooncol; 2019 Jul; 143(3):369-379. PubMed ID: 31049827
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.
Chen H; Xue L; Huang H; Wang H; Zhang X; Zhu W; Wang Z; Wang Z; Wu H
EBioMedicine; 2018 Oct; 36():252-265. PubMed ID: 30274821
[TBL] [Abstract][Full Text] [Related]
19. p53 performs an essential role in mediating the oncogenic stimulus triggered by loss of expression of neurofibromatosis type 2 during
Li X; Chen H; Xue L; Pang X; Zhang X; Zhu Z; Zhu W; Wang Z; Wu H
Oncol Lett; 2017 Aug; 14(2):2223-2231. PubMed ID: 28789444
[TBL] [Abstract][Full Text] [Related]
20. Rac1-Mediated DNA Damage and Inflammation Promote Nf2 Tumorigenesis but Also Limit Cell-Cycle Progression.
Shi Y; Bollam SR; White SM; Laughlin SZ; Graham GT; Wadhwa M; Chen H; Nguyen C; Vitte J; Giovannini M; Toretsky J; Yi C
Dev Cell; 2016 Nov; 39(4):452-465. PubMed ID: 27818180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
